Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-&#954;B signaling pathway.

Lan, Tian; Chen, Bo; Hu, Xianzhe; Cao, Jiafan; Chen, Shiyun; Ding, Xin; Li, Shengwen; Fu, Yanfang; Liu, Huanle; Luo, Duosheng; Rong, Xianglu; Guo, Jiao

Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway.

Lan, Tian; Chen, Bo; Hu, Xianzhe; Cao, Jiafan; Chen, Shiyun; Ding, Xin; Li, Shengwen; Fu, Yanfang; Liu, Huanle; Luo, Duosheng; Rong, Xianglu; Guo, Jiao.

Afiliación

Lan T; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Center, Institute of Chinese Medicine, Guangdong Pharm
Chen B; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Center, Institute of Chinese Medicine, Guangdong Pharm
Hu X; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Center, Institute of Chinese Medicine, Guangdong Pharm
Cao J; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Center, Institute of Chinese Medicine, Guangdong Pharm
Chen S; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: chenshiyun777@163.com.
Ding X; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Center, Institute of Chinese Medicine, Guangdong Pharm
Li S; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Center, Institute of Chinese Medicine, Guangdong Pharm
Fu Y; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: fuyanfang2022@163.com.
Liu H; School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Electronic address: liuhuanletongxue@163.com.
Luo D; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Center, Institute of Chinese Medicine, Guangdong Pharm
Rong X; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Center, Institute of Chinese Medicine, Guangdong Pharm
Guo J; Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangzhou Higher Education Mega Center, Institute of Chinese Medicine, Guangdong Pharm

J Ethnopharmacol ; 321: 117516, 2024 Mar 01.

Article en En | MEDLINE | ID: mdl-38042390

Asunto(s)

Cirrosis Hepática; FN-kappa B; Ratones; Animales; FN-kappa B/metabolismo; Cirrosis Hepática/inducido químicamente; Cirrosis Hepática/tratamiento farmacológico; Cirrosis Hepática/metabolismo; Hígado; Fibrosis; Transducción de Señal; Tetracloruro de Carbono/farmacología; Inflamación/patología; ARN/metabolismo; ARN/farmacología; ARN/uso terapéutico

Palabras clave

CCL2-CCR2 axis; Inflammation; Liver fibrosis; MAPK/NF-κB; Tianhuang formula

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: FN-kappa B / Cirrosis Hepática Idioma: En Revista: J Ethnopharmacol Año: 2024 Tipo del documento: Article